Olga Tennison Autism Research Centre, School of Psychological Science, La Trobe University, Melbourne, Victoria, Australia.
Cooperative Research Centre for Living with Autism (Autism CRC), Long Pocket, Brisbane, Queensland, Australia.
Autism Res. 2018 Feb;11(2):258-269. doi: 10.1002/aur.1872. Epub 2017 Sep 18.
Despite the high frequency of anxiety and depression symptoms in individuals with Autism Spectrum Disorder (ASD) and a significant impact of these comorbidities on both individuals with ASD and their families, research on the validity of anxiety and depression measures in the ASD population is currently lacking. The aim of this study was to explore the psychometric properties of the Hospital Anxiety and Depression Scale [HADS; Zigmond & Snaith, ] in a sample of older adolescents and young adults with ASD. One hundred and fifty one participants (UK Transition longitudinal study: N = 106; 75 males, M = 16.04 years, SD = 1.28; Longitudinal Study of Australian Schools Leavers with ASD: N = 45, 30 males; M = 18.35 years, SD = 2.55) completed the HADS and a range of mental health and well-being measures. Combination of the Principal Component Analysis and Parallel Analysis indicated two factors as an optimal solution in our sample, accounting for 43.77% of variance with factors being identical in terms of content with the structure found in the general population. Internal consistency was good for the HADS anxiety scale (HADS-A; .82-.84) and acceptable for the HADS depression scale (HADS-D; .60-.72). Convergent validity of both HADS-A and HADS-D scales was excellent and divergent validity was acceptable. Our study represents a significant contribution to the literature by providing an initial validation of the HADS in older adolescents and younger adults with ASD. Autism Res 2018, 11: 258-269. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.
Research on the validity of measurement of anxiety and depression in ASD is currently lacking. The aim of this study was to explore the properties of the Hospital Anxiety and Depression Scale (HADS) in a sample of 151 young people with ASD. Participants completed HADS and a range of mental health and well-being measures. Encouragingly, our findings suggest that HADS provides a reliable and valid assessment of anxiety and depression in ASD.
尽管自闭症谱系障碍（ASD）个体中焦虑和抑郁症状的频率很高，并且这些合并症对 ASD 个体及其家庭都有重大影响，但目前缺乏 ASD 人群中焦虑和抑郁测量的有效性研究。本研究旨在探索医院焦虑和抑郁量表[HADS；Zigmond & Snaith，]在 ASD 青少年和年轻成人样本中的心理测量特性。151 名参与者（英国过渡纵向研究：N=106；75 名男性，M=16.04 岁，SD=1.28；自闭症澳大利亚学校毕业生纵向研究：N=45，30 名男性；M=18.35 岁，SD=2.55）完成了 HADS 以及一系列心理健康和幸福感测量。主成分分析和并行分析的组合表明，在我们的样本中，两个因素是最佳解决方案，占方差的 43.77%，并且在内容上与一般人群中的结构相同。HADS 焦虑量表（HADS-A；.82-.84）的内部一致性良好，HADS 抑郁量表（HADS-D；.60-.72）的内部一致性可接受。两个 HADS-A 和 HADS-D 量表的聚合效度均极佳，发散效度可接受。我们的研究通过在 ASD 青少年和年轻成人中对 HADS 进行初步验证，为文献做出了重要贡献。自闭症研究 2018, 11: 258-269. © 2017 自闭症国际研究协会，威利期刊，公司。
目前缺乏关于 ASD 中焦虑和抑郁测量有效性的研究。本研究的目的是在 ASD 青少年样本中探索医院焦虑和抑郁量表（HADS）的特性。参与者完成了 HADS 以及一系列心理健康和幸福感的测量。令人鼓舞的是，我们的研究结果表明，HADS 为 ASD 中的焦虑和抑郁提供了可靠和有效的评估。
